Nigel H. Greig
Laboratory of Neurosciences
Intramural Research Program
National Institute on Aging
National Institutes of Health
USA
Name/email consistency: high
- Tumor necrosis factor-α synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease. Tweedie, D., Ferguson, R.A., Fishman, K., Frankola, K.A., Van Praag, H., Holloway, H.W., Luo, W., Li, Y., Caracciolo, L., Russo, I., Barlati, S., Ray, B., Lahiri, D.K., Bosetti, F., Greig, N.H., Rosi, S. J. Neuroinflammation (2012)
- Apoptotic and behavioral sequelae of mild brain trauma in mice. Tweedie, D., Milman, A., Holloway, H.W., Li, Y., Harvey, B.K., Shen, H., Pistell, P.J., Lahiri, D.K., Hoffer, B.J., Wang, Y., Pick, C.G., Greig, N.H. J. Neurosci. Res. (2007)
- An overview of phenserine tartrate, a novel acetylcholinesterase inhibitor for the treatment of Alzheimer's disease. Greig, N.H., Sambamurti, K., Yu, Q.S., Brossi, A., Bruinsma, G.B., Lahiri, D.K. Current. Alzheimer. Research (2005)
- Anticholinesterase and pharmacokinetic profile of phenserine in healthy elderly human subjects. Greig, N.H., Ruckle, J., Comer, P., Brownell, L., Holloway, H.W., Flanagan, D.R., Canfield, C.J., Burford, R.G. Current. Alzheimer. Research (2005)
- Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent. Greig, N.H., Utsuki, T., Ingram, D.K., Wang, Y., Pepeu, G., Scali, C., Yu, Q.S., Mamczarz, J., Holloway, H.W., Giordano, T., Chen, D., Furukawa, K., Sambamurti, K., Brossi, A., Lahiri, D.K. Proc. Natl. Acad. Sci. U.S.A. (2005)
- New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-alpha inhibitors, and GLP-1 receptor agonists. Greig, N.H., Mattson, M.P., Perry, T., Chan, S.L., Giordano, T., Sambamurti, K., Rogers, J.T., Ovadia, H., Lahiri, D.K. Ann. N. Y. Acad. Sci. (2004)
